Dr. Landen is an Associate Professor, Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Virginia. He completed his fellowship in gynecologic oncology at the University of Texas MD Anderson Cancer Center. He is a member of the CDMRP/Department of Defense Ovarian Cancer Academy and a graduate of the Reproductive Scholar Development Program, dividing his time between clinical care and basic/translational research in ovarian cancer. He is a prior recipient the Foundation/Carol’s Cause Outstanding Paper Award and the Foundation/Sarah Biedenhard Ovarian Cancer Research Grant. He is a full member of the Society of Gynecologic Oncology and the American Association for Cancer Research, and serves on the Board of Directors for the Women’s Cancer Foundation and the Norma Livingston Foundation.
“As FWC enters its 25th year of serving women diagnosed with a gynecologic cancer and those who are at risk, this merger will consolidate all FWC activities for the benefit of our Society and women,” said David. G Mutch, MD, who will serve as Chair of the new FWC.